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● Allergenic risk assessment of proteins:
Safety to consume:
    Evaluate persistence of intact protein and large protein fragments 
in gastrointestinal (GI) tract
Potential sensitisation via duodenum and eventual allergic reaction
● In vitro digestion as a first screening step
 Current pepsin resistance test (PRT) is not physiologically relevant
Naegeli, H., et al., Guidance on allergenicity assessment of genetically modified plants. EFSA Journal, 2017, 15(6), 4862-4911.
Introduction
 Proteins that are not pepsin resistant (Beta-Casein, Soybean 
Lipoxygenase, Acid Phosphatase) show slower kinetics of proteolysis for 
the infant model of digestion
 Intact protein and protein fragments >> 9 amino acids remain 
throughout the intestinal phase for Kunitz Trypsin Inhibitor and 
Concanavalin A regardless of the digestion model
 Peptidomics allow for a precise description of peptides with specific 
behaviours according to the digestion model 
Preliminary results
Methodology
● This project highlights the importance of a multi-test protocol to assess 
protein digestibility. Future studies should include the effect of the food 
processing and/or food matrix on protein digestion.
● A workflow based on free softwares can succesfully be used to quickly :
  convert proprietary MS file formats to open .mzML or .mzXML 
  perform database search → peptide identification 
  align chromatograms and automatically extract peak areas on large 
datasets → relative quantification
perform statistical treatment and automate figure production
Conclusions
● Development and validation of a robust physiologically relevant, in vitro 
digestion protocol to assess stability of purified proteins
● Increase productivity of peptidomics data interpretation using only free 
softwares
Objectives
Stomach:
• Dilution ratio with simulated gastric fluid 
(SGF)
• Acidic pH
• Enzyme activity (pepsin)• Sampling :
 0.5, 2, 5, 10, 20, 30 and 60 min
 Gastric and intestinal phase
 Three digestion protocols 
• Proteolysis stopped with protease 
inhibitors
 Gastric: Pepstatin A
 Intestinal: Pefabloc®
• Shaking incubator: 
 T = 37 °C
 100 rpm
• Digestion run in triplicate
Small intestine:
• Dilution ratio with simulated intestinal fluid 
(SIF)
• Neutral pH
• Enzyme activity (trypsin/chymotrypsin 4/1)
• Biosurfactants: fixed total bile salt 
concentration
Static in vitro digestion models
Harsh conditionsMild conditions
Infant1 Early Phase Adult (INFOGEST)2 Late Phase Adult (PRT)3
(Bile Salts, pH, Enzyme Ratios)
10 proteins 
≠ allergenic profiles
SDS-PAGE: Evaluation of protein 
degradation 
NanoLC-MS/MS: Peptide 
identification and quantification
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